News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No news articles were published in the past hour; no major market-moving headlines emerged.
  • U.S. and European markets showed limited movement amid the lack of new headlines.
  • No central bank statements or economic data releases arrived this hour.
  • No significant geopolitical events or political developments were reported.
  • No major corporate earnings, M&A, or regulatory filings were published this hour.
  • Liquidity appeared typical with no sudden market stress or volatility spikes observed.

Latest Articles

AXT Pullback Creates a Speculative Entry: Upgrade to Buy

AXT Pullback Creates a Speculative Entry: Upgrade to Buy

AXT's share-price correction after an extraordinary rally and a dilutive follow-on offering has created a measurable risk-reward for speculative, mid-horizon traders. The business controls the lion's share of the indium phosphide substrate market and stands to benefit from structural AI data center demand, but valuation remains extreme and executio…

Taiwan Warns Beijing Is Tightening Control Over Air and Sea Near the Island

Taiwan Warns Beijing Is Tightening Control Over Air and Sea Near the Island

Taiwan's defence ministry says an increasingly unpredictable Beijing is expanding its control of the air and maritime domains around the island, centering exercises on joint blockade and control of external sea lanes while studying lessons from recent conflicts abroad. The report highlights a purge of senior Chinese officers, the adoption of tactic…

Change Agents Completes Phase 2 of its Catch-Up Agentic AI Video Studio Platform; Development led by Caylent with Funding from Amazon Web Services Grant

Change Agents Completes Phase 2 of its Catch-Up Agentic AI Video Studio Platform; Development led by Caylent with Funding from Amazon Web Services Grant

Change Agents Corporation has completed Phase 2 development of its Catch-Up agentic AI video studio platform in collaboration with Caylent and with funding from an Amazon Web Services grant. The platform is designed to help digital content creators autonomously generate personalized short-form videos across multiple social media platforms. Beta tes…

OneMedNet’s iRWD Platform Enables Rapid Feasibility-to-Delivery for Leading AI-Driven Drug Development Company

OneMedNet’s iRWD Platform Enables Rapid Feasibility-to-Delivery for Leading AI-Driven Drug Development Company

OneMedNet Corporation announced a new agreement to provide its iRWD platform’s de-identified, full-fidelity clinical real-world data to a leading AI-driven drug development company, enabling rapid cohort feasibility, data validation, contracting, and delivery within weeks. This underscores the growing demand for private, directly sourced clinical d…

Strategy Inc. Resumes Bitcoin Buying After Ten-Week Liquidation Pause

Strategy Inc. Resumes Bitcoin Buying After Ten-Week Liquidation Pause

Strategy Inc. has returned to accumulating Bitcoin, acquiring 4,603 coins between August 24 and 30 for $369.7 million. The purchases, funded by at-the-market equity sales, were signaled publicly by Executive Chairman Michael Saylor and confirmed in an SEC 8-K. The company now holds 845,050 BTC at a blended cost basis of $75,412 per coin.

American Battery Technology Company Hosts DOE Leadership to Showcase Commercial Technologies Strengthening U.S. Critical Minerals Supply Chains

American Battery Technology Company Hosts DOE Leadership to Showcase Commercial Technologies Strengthening U.S. Critical Minerals Supply Chains

American Battery Technology Company hosted senior U.S. Department of Energy and Nevada state leaders at their commercial lithium-ion battery recycling facility and lithium hydroxide pilot plant. The visit highlighted the company's DOE-supported technologies that enhance domestic lithium resource development and recycling to reduce reliance on forei…

Chloe Kim Teams Up with Qelbree®, the #1 Prescribed Branded Non-Stimulant ADHD Treatment*, to Help Empower People Navigating ADHD

Chloe Kim Teams Up with Qelbree®, the #1 Prescribed Branded Non-Stimulant ADHD Treatment*, to Help Empower People Navigating ADHD

Supernus Pharmaceuticals announced a partnership with professional snowboarder Chloe Kim to raise awareness about adult ADHD and promote Qelbree, their non-stimulant ADHD medication. Qelbree, approved by the FDA five years ago, has become the top prescribed branded non-stimulant ADHD treatment with 3 million prescriptions. The collaboration aims to…

Smackover Lithium Signs Binding Customer Offtake with LG Energy Solution for the South West Arkansas Project

Smackover Lithium Signs Binding Customer Offtake with LG Energy Solution for the South West Arkansas Project

Standard Lithium's Smackover Lithium partnership has executed a binding 10-year offtake agreement with LG Energy Solution for 8,000 metric tonnes per year of battery-quality lithium carbonate from the South West Arkansas Project. This deal complements a prior contract with Trafigura and secures approximately 90% of the expected output, strengthenin…

IperionX Secures Second U.S. Army Task Order to Accelerate Industrial-Scale American Titanium Production

IperionX Secures Second U.S. Army Task Order to Accelerate Industrial-Scale American Titanium Production

IperionX Limited announces the U.S. Army awarded a second task order worth a base $18.5 million (with potential to reach $25.4 million) under its $99 million SBIR Phase III contract to scale industrial-scale, domestic titanium powder-to-part manufacturing capacity. This funding supports expanding titanium fastener finishing capabilities in Virginia…

Endovia Health Sciences Welcomes Historic Shift in Federal Cannabinoid Policy; Advances CannEpil® FDA Submission and Expands Development Pipeline

Endovia Health Sciences Welcomes Historic Shift in Federal Cannabinoid Policy; Advances CannEpil® FDA Submission and Expands Development Pipeline

Endovia Health Sciences welcomes the federal government's recent support for transferring marijuana from Schedule I to Schedule III, which marks a significant evolution in U.S. cannabinoid policy and is expected to facilitate scientific research and regulatory approval of cannabinoid-based medicines. The company plans to submit its CannEpil® formul…

Datacentrex Invests $30 Million in Eagle LNG Partners, a Supplier of Fuel for the U.S. Space Launch Industry

Datacentrex Invests $30 Million in Eagle LNG Partners, a Supplier of Fuel for the U.S. Space Launch Industry

Datacentrex, Inc. (Nasdaq: DTCX) announced a $30 million investment in Eagle LNG Partners via the equity holding company ELNG Equity LLC. Eagle LNG produces aerospace-specification liquefied natural gas (LNG) used to fuel next-generation American reusable launch vehicles and has established long-term contracts since 2017. The move positions Datacen…

NeoVolta Announces Strategic U.S. Battery Cell Supply and BESS Manufacturing Collaboration with SK On

NeoVolta Announces Strategic U.S. Battery Cell Supply and BESS Manufacturing Collaboration with SK On

NeoVolta Inc. announced a strategic five-year agreement with SK On to secure 9 GWh of U.S.-manufactured lithium iron phosphate (LFP) battery cells from 2027 through 2031. Additionally, the companies will collaborate on an expanded framework where SK On supplies an additional 9 GWh of cells and NeoVolta manufactures energy storage packs for SK On, t…

Lexicon Announces New Post Hoc SOLOIST-WHF Analysis Demonstrating Consistent Sotagliflozin Results Across Baseline Blood Pressure Levels in Patients with Recent Worsening Heart Failure

Lexicon Announces New Post Hoc SOLOIST-WHF Analysis Demonstrating Consistent Sotagliflozin Results Across Baseline Blood Pressure Levels in Patients with Recent Worsening Heart Failure

Lexicon Pharmaceuticals announced results from a post hoc analysis of their Phase 3 SOLOIST-WHF trial, demonstrating sotagliflozin's consistent efficacy and safety across various baseline systolic blood pressure levels in patients recently hospitalized for worsening heart failure. The treatment reduced cardiovascular death and heart failure-related…